Newsletter | October 3, 2019

10.03.19 -- Cell & Gene Best Of September

 

Hello Cell & Gene readers,

 

I’m happy to bring you September’s most-clicked articles. Enjoy.

 

Erin Harris, editor in chief
Follow me on Twitter

September's Best Featured Editorial
What’s A Cure Worth? ICER Publishes Value Assessment Framework For Curative Therapies
By Yulia Privolnev, manager, global market access, Decision Resources Group (DRG)
Determining how to evaluate — and whether to reimburse potentially curative one-time cell and gene therapies — is a challenge for payers, before even getting to negotiating prices and figuring out how to pay for them.
Does Blockchain Make Sense For The Cell & Gene Therapy Supply Chain?
By Carla Reed, president, New Creed LLC
The FDA is actively supporting blockchain initiatives for the life sciences industry in the U.S., announcing in June 2019 that it will be sponsoring a pilot for a public, permissioned blockchain to track, trace, and authenticate life sciences materials and products.
The Three Pillars Of Patient Advocacy In Industry
By Erin Harris, Editor-In-Chief, Cell & Gene
Jamie Ring, Head of Patient Advocacy at Spark Therapeutics and Cell & Gene Editorial Advisory Board member shares with me valuable information about role of patient advocacy in industry.
September's Best Industry Insights
Provocative Questions For CAR T Cell Therapy Scientists
By Stephen Minger, Ph.D./Industry Consultant, Scientific Advisor: Cell and gene therapy

The FDA approval of two cell therapies is a major milestone on an exciting journey of discovery. What are some of the important questions still being explored?

An Introduction To Biopharmaceutical Facility Design & Layout
By Herman Bozenhardt, Bozenhardt Consulting Services, and Erich Bozenhardt, IPS-Integrated Project Services

This article explores modern facility design principles that make use of the most flexible new technologies and provide a platform to rein in costs, reduce schedules, and deliver products compliantly and within business risk tolerance.

Tube Welders vs. Aseptic Connectors
By CPC

Tube welding versus using aseptic connectors—as with any debate, there are strong opinions on both sides. Following are some factors to consider that may tip the scale in favor of aseptic connectors.

Connect With Cell & Gene:
      Twitter